ML-016(BrYet)

N/A

Report date: 2025/10/15 15:52:42

Base Information

Drug NameML-016(BrYet)
Drug Alias NameML-016
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesBrYet US Inc
China Registration ClassN/A

Develop Information

Active CompaniesBrYet US Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A